Results 221 to 230 of about 58,549 (319)

Impact of Underlying Portal Hypertension on Severity and Course of Acute-On-Chronic Liver Failure. [PDF]

Liver Int
ABSTRACT Background and Aims The impact of portal hypertension (PH) during acute‐on‐chronic liver failure (ACLF) remains unclear. This study investigated the link between underlying PH severity, systemic inflammation (SI), and the course of ACLF. Methods Consecutive patients with ACLF (n = 192) who met the EASL‐CLIF criteria were retrospectively ...
Taru V, Kramer G, Hofer BS, Dominik N, Balcar L, Schneeweiss-Gleixner M, Procopet B, Trauner M, Mandorfer M, Schwabl P, Reiberger T, Simbrunner B.   +11 more
europepmc   +2 more sources

Recombinant factor VIIa (NovoSeven®) for post‐prostatectomy hemorrhage in a patient with type I von Willebrand disease [PDF]

, 2001
Michael D. Tarantino, Rozanne Aberle
openalex   +1 more source

The Role of Genetics in Stroke Risk and Outcome: A Review of Current Evidence

Brain and Behavior, Volume 15, Issue 10, October 2025.
This study delineates the multiple pathways leading to stroke, encompassing genetic risk factors such as lipid/cholesterol metabolism, blood pressure regulation genes, and endothelial dysfunction. The report includes genetic pathways such as Val66Met polymorphism, prothrombin G20210A, interleukin‐6 and tumor necrosis factor gene variant, along with ...
Mega Obukohwo Oyovwi, Benneth Ben‐Azu, Ejayeta Jeroh, Faith B. Friday   +3 more
wiley   +1 more source

2025 ASH ISTH NBDF WFH monitoring report on the 2021 clinical guidelines on the diagnosis and management of von Willebrand disease. [PDF]

Blood Adv
James PD, Flood VH, Connell NT.
europepmc   +1 more source

Use of the collagen‐binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay [PDF]

, 2002
Anne Riddell, P. Vincent Jenkins, Ioana Nitu-Whalley, A. McCraw, Christine A. Lee, Simon Brown   +5 more
openalex   +1 more source

Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2‐Low Breast Cancer With Cancer‐Related Microangiopathic Hemolytic Anemia: A Case Report

Cancer Innovation, Volume 4, Issue 5, October 2025.
The diagnosis and treatment of acquired hemolytic anemia can be challenging. In breast cancer patients, it may be directly associated with the underlying malignancy (as an initial presentation or during disease progression). The diagnosis of cancer‐related microangiopathic hemolytic anemia (CR‐MAHA) is often delayed, and patients have a high mortality ...
Mengyuan Li, Mao Ding, Yukun Hou, Xuening Duan, Yuanjia Cheng, Ling Xu   +5 more
wiley   +1 more source

The Impact of Basal Inflammatory Status on Post-CABG Atrial and Ventricular Ectopy and Remodeling Pathways. [PDF]

Medicina (Kaunas)
Cozac DA, Somkereki C, Huțanu A, Nicoara TR, Scridon A.   +4 more
europepmc   +1 more source

Force-induced on-rate switching and modulation by mutations in gain-of-function von Willebrand diseases. [PDF]

Proc Natl Acad Sci U S A, 2015
Kim J, Hudson NE, Springer TA.
europepmc   +1 more source

Pathobiochemistry of Sepsis [PDF]

, 1986
Duswald, Karl-Heimo, Fritz, Hans, Inthorn, D., Jochum, Marianne, Welter, H. F., Witte, J.   +5 more
core   +1 more source

A Case of an Acquired Factor V Inhibitor Triggered by Levofloxacin and Ceftazidime and Effectively Treated With Clinical Pharmacist Assistance

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Acquired factor V inhibitor is a rare and clinically challenging condition that can manifest across a spectrum ranging from asymptomatic laboratory abnormalities to life‐threatening hemorrhagic episodes. This case reports a patient with antibiotic‐associated AFVI, who presents asymptomatically and may be managed conservatively with close ...
Chunjuan Zhao, Weibu Chen, Xueyan Chen
wiley   +1 more source